Ventavis Price To Be Based On Input From Payors And Physicians, CoTherix Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CoTherix will base its price for the inhaled pulmonary arterial hypertension therapy Ventavis on the outcome of ongoing discussions with payors and physicians